MERCK & CO., INC. (MRK)
Clinical trial NCT05535868 updates: 1. status: UNKNOWN → COMPLETED 2. completion date: 2023-08-31 → 2023-11-21 3. primary completion date: 2023-08-01 → 2023-11-21 4. enrollment: 117 → 91 participants 5. enrollment type: ESTIMATED → ACTUAL 6. intervention model: PARALLEL → SEQUENTIAL 7. collaborators added: University of Oxford, Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Liverpool University Hospitals NHS Foundation Trust
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical